Ricky Goldwasser

Q: What is Ricky Goldwasser's success rate?

Ricky Goldwasser currently has a success rate of 100.

Q: What is the average return of Ricky Goldwasser's calls?

Their stock ratings have generated an average return of 28.0457476654186.

Morgan Stanley | Healthcare

Ricky Goldwasser is an analyst from Morgan Stanley specializing in the Healthcare sector. Ranked #533 out of 4771 analysts, they have issued 12 stock ratings with a success rate of 100.00% and an average return of 28.05%.

With 12 ratings to date, Ricky Goldwasser is beginning to establish credibility in the Healthcare sector. They have achieved a success rate of 100.00% and an average return of 28.05%, highlighting promising potential as their track record develops further.

#533

Out of 4771

Total Ratings

+100.00%

Success Rate

+28.05%

Average Return

Recent Ratings Analysis

LH

Buy

Jul 31, 2026

Target

$338.00

Current

$306.96

Performance

-0.72%

Ricky Goldwasser rated LH as Overweight on Jul 31, 2026, setting a price target of 338. Shares have remained stable near 306.96, leaving the 338 target still in play.

CRL

Buy

Jul 09, 2026

Target

$260.00

Current

$273.00

Performance

16.87%

On Jul 09, 2026, CRL was given a Overweight rating by Ricky Goldwasser, with a target price of 260. The stock rallied 16.87% after the rating, narrowing the gap to the target of 260 and validating the bullish stance.

CNC

Hold

Jun 04, 2026

Target

$57.00

Current

$65.40

Performance

4.31%

CNC received a Equal-Weight rating from Ricky Goldwasser on Jun 04, 2026, aiming for 57. Shares remained flat at 65.4, aligning with the neutral rating.

DOCS

Buy

May 14, 2026

Target

$35.00

Current

$24.71

Performance

37.20%

On May 14, 2026, Ricky Goldwasser published a Overweight outlook on DOCS, with a target of 35. Shares gained 37.20%, underscoring the accuracy of the bullish outlook toward 35.

UNH

Buy

Jan 23, 2026

Target

$409.00

Current

$388.28

Performance

8.99%

Ricky Goldwasser on Jan 23, 2026 assigned UNH a Overweight rating, with a price target of 409. The Buy call aligned well with market performance, producing a gain of 8.99%.

ACCD

Hold

Dec 17, 2024

Target

$5.00

Current

$7.02

Performance

106.47%

On Dec 17, 2024, Ricky Goldwasser reaffirmed ACCD with a Equal-Weight rating, targeting 5. Market strength beyond 7.02 went further than the conservative outlook suggested.

Frequency Asked Questions

Who is Ricky Goldwasser?

Ricky Goldwasser is an analyst from Morgan Stanley specializing in the Healthcare sector.

What is Ricky Goldwasser's success rate?

Ricky Goldwasser currently has a success rate of +100.00%.

How many ratings has Ricky Goldwasser issued?

Ricky Goldwasser has issued 12 stock ratings so far.

What is the average return of Ricky Goldwasser's calls?

Their stock ratings have generated an average return of +28.05%.

What is Ricky Goldwasser's ranking?

Ricky Goldwasser is ranked #533 out of 4771 analysts.

What types of ratings does Ricky Goldwasser give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Ricky Goldwasser?

You can follow Ricky Goldwasser by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Ricky Goldwasser?

Their latest rating was a Buy on LH issued on 2026-07-31.